As we discussed earlier, a variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel...more
Dr. Stephen Thaler created an AI algorithm (named DABUS) that includes multiple neural networks trained in different linguistic subspaces that connect dynamically in a manner based on controlled chaos. DABUS also includes a...more
Dr. Stephen Thaler created an artificial-intelligence algorithm – named Device for the Autonomous Bootstrapping of Unified Sentience (DABUS) – that includes multiple neural networks (each trained in a given linguistic...more
A variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel biological targets and...more
In a recent article, Kilpatrick Townsend’s Kate Gaudry and Mark P. Mathison summarized current non-invasive brain-machine interface technology and theorized its effect on patent law if its advancement flourishes like that of...more
Kilpatrick Townsend’s Kate Gaudry and Rodney Rothwell recently participated in the Association of Corporate Counsel’s National Capital Region’s Summer Series: “Protecting Artificial Intelligence (AI) Innovations – Unique...more